Porton Pharma Solutions Ltd. (SZSE:300363) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at a price of not more than CNY 85 per share.

The shares purchased will be used for the company's equity incentive plan or ESOP. The plan shall be funded through company's own funds. The program will be valid till 12 months.